<!DOCTYPE sequence-cwu SYSTEM "us-sequence-listing-2004-03-09.dtd" [ ]>
<sequence-cwu id="SEQLST-1">
<publication-reference>
<document-id>
<country>US</country>
<doc-number>08623833</doc-number>
<kind>B2</kind>
<date>20140107</date>
</document-id>
</publication-reference>
<number>1</number>
<sequence-list-new-rules>
<s100>
<s160>57</s160>
</s100>
<s200>
<s210>1</s210>
<s211>5</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial SequenceArg
      homopolymer R5, Arg oligomer</s223>
</s220>
</s200>
<s400> 1
Arg Arg Arg Arg Arg
  1               5
</s400>
<s200>
<s210>2</s210>
<s211>6</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial SequenceArg
      homopolymer R6, Arg oligomer</s223>
</s220>
</s200>
<s400> 2
Arg Arg Arg Arg Arg Arg
  1               5
</s400>
<s200>
<s210>3</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial SequenceArg
      homopolymer R7, heptamer of L-Arg, hepta-L-Arg, Arg oligomer</s223>
</s220>
</s200>
<s400> 3
Arg Arg Arg Arg Arg Arg Arg
  1               5
</s400>
<s200>
<s210>4</s210>
<s211>8</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial SequenceArg
      homopolymer R8, Arg oligomer</s223>
</s220>
</s200>
<s400> 4
Arg Arg Arg Arg Arg Arg Arg Arg
  1               5
</s400>
<s200>
<s210>5</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial SequenceArg
      homopolymer R9, Arg oligomer</s223>
</s220>
</s200>
<s400> 5
Arg Arg Arg Arg Arg Arg Arg Arg Arg
  1               5
</s400>
<s200>
<s210>6</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequenceheptamer of
      L-Arg chemical after pH dependent chemical release</s223>
</s220>
</s200>
<s400> 6
Xaa Arg Arg Arg Arg Arg Arg
  1               5
</s400>
<s200>
<s210>7</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequenceunlabeled
      peptide</s223>
</s220>
</s200>
<s400> 7
Arg Arg Arg Arg Arg Arg Arg Gly Gly Xaa
  1               5                  10
</s400>
<s200>
<s210>8</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequenceanalog of
      HIV-1 tat protein basic region Tat-49-57</s223>
</s220>
</s200>
<s400> 8
Xaa Lys Lys Arg Arg Gln Arg Arg Arg
  1               5
</s400>
<s200>
<s210>9</s210>
<s211>8</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial SequenceTat-49-56
      truncated analog of HIV-1 tat protein basic region
      Tat-49-57</s223>
</s220>
</s200>
<s400> 9
Xaa Lys Lys Arg Arg Gln Arg Arg
  1               5
</s400>
<s200>
<s210>10</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial SequenceTat-49-55
      truncated analog of HIV-1 tat protein basic region
      Tat-49-57</s223>
</s220>
</s200>
<s400> 10
Xaa Lys Lys Arg Arg Gln Arg
  1               5
</s400>
<s200>
<s210>11</s210>
<s211>8</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial SequenceTat-50-57
      truncated analog of HIV-1 tat protein basic region
      Tat-49-57</s223>
</s220>
</s200>
<s400> 11
Xaa Lys Arg Arg Gln Arg Arg Arg
  1               5
</s400>
<s200>
<s210>12</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial SequenceTat-51-57
      truncated analog of HIV-1 tat protein basic region
      Tat-49-57</s223>
</s220>
</s200>
<s400> 12
Xaa Arg Arg Gln Arg Arg Arg
  1               5
</s400>
<s200>
<s210>13</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial SequenceA-49
      Ala-substituted analog of HIV-1 tat protein basic
      region Tat-49-57</s223>
</s220>
</s200>
<s400> 13
Xaa Lys Lys Arg Arg Gln Arg Arg Arg
  1               5
</s400>
<s200>
<s210>14</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial SequenceA-50
      Ala-substituted analog of HIV-1 tat protein basic
      region Tat-49-57</s223>
</s220>
</s200>
<s400> 14
Xaa Ala Lys Arg Arg Gln Arg Arg Arg
  1               5
</s400>
<s200>
<s210>15</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial SequenceA-51
      Ala-substituted analog of HIV-1 tat protein basic
      region Tat-49-57</s223>
</s220>
</s200>
<s400> 15
Xaa Lys Ala Arg Arg Gln Arg Arg Arg
  1               5
</s400>
<s200>
<s210>16</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial SequenceA-52
      Ala-substituted analog of HIV-1 tat protein basic
      region Tat-49-57</s223>
</s220>
</s200>
<s400> 16
Xaa Lys Lys Ala Arg Gln Arg Arg Arg
  1               5
</s400>
<s200>
<s210>17</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial SequenceA-53
      Ala-substituted analog of HIV-1 tat protein basic
      region Tat-49-57</s223>
</s220>
</s200>
<s400> 17
Xaa Lys Lys Arg Ala Gln Arg Arg Arg
  1               5
</s400>
<s200>
<s210>18</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial SequenceA-54
      Ala-substituted analog of HIV-1 tat protein basic
      region Tat-49-57</s223>
</s220>
</s200>
<s400> 18
Xaa Lys Lys Arg Arg Ala Arg Arg Arg
  1               5
</s400>
<s200>
<s210>19</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial SequenceA-55
      Ala-substituted analog of HIV-1 tat protein basic
      region Tat-49-57</s223>
</s220>
</s200>
<s400> 19
Xaa Lys Lys Arg Arg Gln Ala Arg Arg
  1               5
</s400>
<s200>
<s210>20</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial SequenceA-56
      Ala-substituted analog of HIV-1 tat protein basic
      region Tat-49-57</s223>
</s220>
</s200>
<s400> 20
Xaa Lys Lys Arg Arg Gln Arg Ala Arg
  1               5
</s400>
<s200>
<s210>21</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial SequenceA-57
      Ala-substituted analog of HIV-1 tat protein basic
      region Tat-49-57</s223>
</s220>
</s200>
<s400> 21
Xaa Lys Lys Arg Arg Gln Arg Arg Ala
  1               5
</s400>
<s200>
<s210>22</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial SequenceTat-57-49
      retro-isomer of HIV-1 tat protein basic region
      Tat-49-57</s223>
</s220>
</s200>
<s400> 22
Xaa Arg Arg Gln Arg Arg Lys Lys Arg
  1               5
</s400>
<s200>
<s210>23</s210>
<s211>5</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial SequenceArg oligomer
      R5, Arg homopolymer</s223>
</s220>
</s200>
<s400> 23
Xaa Arg Arg Arg Arg
  1               5
</s400>
<s200>
<s210>24</s210>
<s211>6</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial SequenceArg oligomer
      R6, Arg homopolymer</s223>
</s220>
</s200>
<s400> 24
Xaa Arg Arg Arg Arg Arg
  1               5
</s400>
<s200>
<s210>25</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial SequenceArg oligomer
      R7, Arg homopolymer</s223>
</s220>
</s200>
<s400> 25
Xaa Arg Arg Arg Arg Arg Arg
  1               5
</s400>
<s200>
<s210>26</s210>
<s211>8</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial SequenceArg oligomer
      R8, Arg homopolymer</s223>
</s220>
</s200>
<s400> 26
Xaa Arg Arg Arg Arg Arg Arg Arg
  1               5
</s400>
<s200>
<s210>27</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial SequenceArg oligomer
      R9, Arg homopolymer</s223>
</s220>
</s200>
<s400> 27
Xaa Arg Arg Arg Arg Arg Arg Arg Arg
  1               5
</s400>
<s200>
<s210>28</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial SequenceHIV-1 tat
      protein basic region Tat-49-57</s223>
</s220>
</s200>
<s400> 28
Arg Lys Lys Arg Arg Gln Arg Arg Arg
  1               5
</s400>
<s200>
<s210>29</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial SequenceAntennapedia
      homeodomain, Antennapedia-43-58</s223>
</s220>
</s200>
<s400> 29
Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys
  1               5                  10                  15
</s400>
<s200>
<s210>30</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial SequenceAntennapedia
      homeodomain, Antennapedia-43-58</s223>
</s220>
</s200>
<s400> 30
Xaa Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys
  1               5                  10                  15
</s400>
<s200>
<s210>31</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial
      Sequencepeptide-aminocaproic acid-DTPA complex</s223>
</s220>
</s200>
<s400> 31
Xaa Arg Arg Arg Arg Arg Arg
  1               5
</s400>
<s200>
<s210>32</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial
      SequenceNH-2R-7CCONH-2.8TFA transporter conjugate</s223>
</s220>
</s200>
<s400> 32
Arg Arg Arg Arg Arg Arg Xaa
  1               5
</s400>
<s200>
<s210>33</s210>
<s211>7</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequenceamino acid
      oligomer delivery enhancing transport moiety</s223>
</s220>
</s200>
<s400> 33
Arg Xaa Arg Arg Xaa Arg Arg
  1               5
</s400>
<s200>
<s210>34</s210>
<s211>10</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequenceamino acid
      oligomer delivery enhancing transport moiety</s223>
</s220>
</s200>
<s400> 34
Arg Xaa Arg Arg Xaa Arg Arg Xaa Arg Arg
  1               5                  10
</s400>
<s200>
<s210>35</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequenceamino acid
      oligomer delivery enhancing transport moiety</s223>
</s220>
</s200>
<s400> 35
Arg Xaa Arg Arg Xaa Arg Arg Xaa Arg Arg Xaa Arg Arg
  1               5                  10
</s400>
<s200>
<s210>36</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequenceamino acid
      oligomer delivery enhancing transport moiety</s223>
</s220>
</s200>
<s400> 36
Arg Xaa Arg Arg Xaa Arg Arg Xaa Arg Arg Xaa Arg Arg Xaa Arg Arg
  1               5                  10                  15
</s400>
<s200>
<s210>37</s210>
<s211>9</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequenceamino acid
      oligomer delivery enhancing transport moiety</s223>
</s220>
</s200>
<s400> 37
Arg Xaa Arg Xaa Arg Xaa Arg Xaa Arg
  1               5
</s400>
<s200>
<s210>38</s210>
<s211>11</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequenceamino acid
      oligomer delivery enhancing transport moiety</s223>
</s220>
</s200>
<s400> 38
Arg Xaa Arg Xaa Arg Xaa Arg Xaa Arg Xaa Arg
  1               5                  10
</s400>
<s200>
<s210>39</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequenceamino acid
      oligomer delivery enhancing transport moiety</s223>
</s220>
</s200>
<s400> 39
Arg Xaa Arg Xaa Arg Xaa Arg Xaa Arg Xaa Arg Xaa Arg
  1               5                  10
</s400>
<s200>
<s210>40</s210>
<s211>15</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequenceamino acid
      oligomer delivery enhancing transport moiety</s223>
</s220>
</s200>
<s400> 40
Arg Xaa Arg Xaa Arg Xaa Arg Xaa Arg Xaa Arg Xaa Arg Xaa Arg
  1               5                  10                  15
</s400>
<s200>
<s210>41</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequenceamino acid
      oligomer delivery enhancing transport moiety</s223>
</s220>
</s200>
<s400> 41
Arg Xaa Arg Xaa Arg Xaa Arg Xaa Arg Xaa Arg Xaa Arg Xaa Arg Xaa
  1               5                  10                  15
Arg
</s400>
<s200>
<s210>42</s210>
<s211>19</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequenceamino acid
      oligomer delivery enhancing transport moiety</s223>
</s220>
</s200>
<s400> 42
Arg Xaa Arg Xaa Arg Xaa Arg Xaa Arg Xaa Arg Xaa Arg Xaa Arg Xaa
  1               5                  10                  15
Arg Xaa Arg
</s400>
<s200>
<s210>43</s210>
<s211>21</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequenceamino acid
      oligomer delivery enhancing transport moiety</s223>
</s220>
</s200>
<s400> 43
Arg Xaa Arg Xaa Arg Xaa Arg Xaa Arg Xaa Arg Xaa Arg Xaa Arg Xaa
  1               5                  10                  15
Arg Xaa Arg Xaa Arg
             20
</s400>
<s200>
<s210>44</s210>
<s211>13</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequenceamino acid
      oligomer delivery enhancing transport moiety</s223>
</s220>
</s200>
<s400> 44
Arg Xaa Xaa Arg Xaa Xaa Arg Xaa Xaa Arg Xaa Xaa Arg
  1               5                  10
</s400>
<s200>
<s210>45</s210>
<s211>16</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequenceamino acid
      oligomer delivery enhancing transport moiety</s223>
</s220>
</s200>
<s400> 45
Arg Xaa Xaa Arg Xaa Xaa Arg Xaa Xaa Arg Xaa Xaa Arg Xaa Xaa Arg
  1               5                  10                  15
</s400>
<s200>
<s210>46</s210>
<s211>19</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequenceamino acid
      oligomer delivery enhancing transport moiety</s223>
</s220>
</s200>
<s400> 46
Arg Xaa Xaa Arg Xaa Xaa Arg Xaa Xaa Arg Xaa Xaa Arg Xaa Xaa Arg
  1               5                  10                  15
Xaa Xaa Arg
</s400>
<s200>
<s210>47</s210>
<s211>22</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequenceamino acid
      oligomer delivery enhancing transport moiety</s223>
</s220>
</s200>
<s400> 47
Arg Xaa Xaa Arg Xaa Xaa Arg Xaa Xaa Arg Xaa Xaa Arg Xaa Xaa Arg
  1               5                  10                  15
Xaa Xaa Arg Xaa Xaa Arg
             20
</s400>
<s200>
<s210>48</s210>
<s211>25</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequenceamino acid
      oligomer delivery enhancing transport moiety</s223>
</s220>
</s200>
<s400> 48
Arg Xaa Xaa Arg Xaa Xaa Arg Xaa Xaa Arg Xaa Xaa Arg Xaa Xaa Arg
  1               5                  10                  15
Xaa Xaa Arg Xaa Xaa Arg Xaa Xaa Arg
             20                  25
</s400>
<s200>
<s210>49</s210>
<s211>28</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequenceamino acid
      oligomer delivery enhancing transport moiety</s223>
</s220>
</s200>
<s400> 49
Arg Xaa Xaa Arg Xaa Xaa Arg Xaa Xaa Arg Xaa Xaa Arg Xaa Xaa Arg
  1               5                  10                  15
Xaa Xaa Arg Xaa Xaa Arg Xaa Xaa Arg Xaa Xaa Arg
             20                  25
</s400>
<s200>
<s210>50</s210>
<s211>31</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequenceamino acid
      oligomer delivery enhancing transport moiety</s223>
</s220>
</s200>
<s400> 50
Arg Xaa Xaa Arg Xaa Xaa Arg Xaa Xaa Arg Xaa Xaa Arg Xaa Xaa Arg
  1               5                  10                  15
Xaa Xaa Arg Xaa Xaa Arg Xaa Xaa Arg Xaa Xaa Arg Xaa Xaa Arg
             20                  25                  30
</s400>
<s200>
<s210>51</s210>
<s211>17</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequenceamino acid
      oligomer delivery enhancing transport moiety</s223>
</s220>
</s200>
<s400> 51
Arg Xaa Xaa Xaa Arg Xaa Xaa Xaa Arg Xaa Xaa Xaa Arg Xaa Xaa Xaa
  1               5                  10                  15
Arg
</s400>
<s200>
<s210>52</s210>
<s211>21</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequenceamino acid
      oligomer delivery enhancing transport moiety</s223>
</s220>
</s200>
<s400> 52
Arg Xaa Xaa Xaa Arg Xaa Xaa Xaa Arg Xaa Xaa Xaa Arg Xaa Xaa Xaa
  1               5                  10                  15
Arg Xaa Xaa Xaa Arg
             20
</s400>
<s200>
<s210>53</s210>
<s211>25</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequenceamino acid
      oligomer delivery enhancing transport moiety</s223>
</s220>
</s200>
<s400> 53
Arg Xaa Xaa Xaa Arg Xaa Xaa Xaa Arg Xaa Xaa Xaa Arg Xaa Xaa Xaa
  1               5                  10                  15
Arg Xaa Xaa Xaa Arg Xaa Xaa Xaa Arg
             20                  25
</s400>
<s200>
<s210>54</s210>
<s211>29</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequenceamino acid
      oligomer delivery enhancing transport moiety</s223>
</s220>
</s200>
<s400> 54
Arg Xaa Xaa Xaa Arg Xaa Xaa Xaa Arg Xaa Xaa Xaa Arg Xaa Xaa Xaa
  1               5                  10                  15
Arg Xaa Xaa Xaa Arg Xaa Xaa Xaa Arg Xaa Xaa Xaa Arg
             20                  25
</s400>
<s200>
<s210>55</s210>
<s211>33</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequenceamino acid
      oligomer delivery enhancing transport moiety</s223>
</s220>
</s200>
<s400> 55
Arg Xaa Xaa Xaa Arg Xaa Xaa Xaa Arg Xaa Xaa Xaa Arg Xaa Xaa Xaa
  1               5                  10                  15
Arg Xaa Xaa Xaa Arg Xaa Xaa Xaa Arg Xaa Xaa Xaa Arg Xaa Xaa Xaa
             20                  25                  30
Arg
</s400>
<s200>
<s210>56</s210>
<s211>37</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequenceamino acid
      oligomer delivery enhancing transport moiety</s223>
</s220>
</s200>
<s400> 56
Arg Xaa Xaa Xaa Arg Xaa Xaa Xaa Arg Xaa Xaa Xaa Arg Xaa Xaa Xaa
  1               5                  10                  15
Arg Xaa Xaa Xaa Arg Xaa Xaa Xaa Arg Xaa Xaa Xaa Arg Xaa Xaa Xaa
             20                  25                  30
Arg Xaa Xaa Xaa Arg
         35
</s400>
<s200>
<s210>57</s210>
<s211>41</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Description of Artificial Sequenceamino acid
      oligomer delivery enhancing transport moiety</s223>
</s220>
</s200>
<s400> 57
Arg Xaa Xaa Xaa Arg Xaa Xaa Xaa Arg Xaa Xaa Xaa Arg Xaa Xaa Xaa
  1               5                  10                  15
Arg Xaa Xaa Xaa Arg Xaa Xaa Xaa Arg Xaa Xaa Xaa Arg Xaa Xaa Xaa
             20                  25                  30
Arg Xaa Xaa Xaa Arg Xaa Xaa Xaa Arg
         35                  40
</s400>
</sequence-list-new-rules>
</sequence-cwu>
